Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Polomar Health Services (PMHS) EBITDA (2022 - 2025)

Polomar Health Services has reported EBITDA over the past 4 years, most recently at -$628808.0 for Q3 2025.

  • Quarterly results put EBITDA at -$628808.0 for Q3 2025, down 142.62% from a year ago — trailing twelve months through Sep 2025 was -$2.3 million (down 225.8% YoY), and the annual figure for FY2024 was -$1.3 million, down 194.78%.
  • EBITDA for Q3 2025 was -$628808.0 at Polomar Health Services, down from -$563333.0 in the prior quarter.
  • Over the last five years, EBITDA for PMHS hit a ceiling of -$13518.0 in Q3 2022 and a floor of -$689112.0 in Q4 2024.
  • Median EBITDA over the past 4 years was -$156222.5 (2022), compared with a mean of -$249730.4.
  • Peak annual rise in EBITDA hit 37.8% in 2023, while the deepest fall reached 896.29% in 2023.
  • Polomar Health Services' EBITDA stood at -$151977.0 in 2022, then soared by 37.8% to -$94537.0 in 2023, then plummeted by 628.93% to -$689112.0 in 2024, then grew by 8.75% to -$628808.0 in 2025.
  • The last three reported values for EBITDA were -$628808.0 (Q3 2025), -$563333.0 (Q2 2025), and -$415408.0 (Q1 2025) per Business Quant data.